Your browser doesn't support javascript.
loading
BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimetics.
Pan, Rongqing Aaron; Wang, Youzhen; Qiu, Shumei; Villalobos-Ortiz, Mariana; Ryan, Jeremy; Morris, Erick; Halilovic, Ensar; Letai, Anthony.
Afiliação
  • Pan RA; Bone Marrow Transplantation Center of the First Affiliated Hospital and Institute of Hematology and Department of Immunology, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical
  • Wang Y; Novartis Institute of Biomedical Research, Oncology Drug Discovery, Cambridge, MA 02139.
  • Qiu S; Novartis Institute of Biomedical Research, Oncology Drug Discovery, Cambridge, MA 02139.
  • Villalobos-Ortiz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA ; Harvard Medical School, Boston, MA 02215.
  • Ryan J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA ; Harvard Medical School, Boston, MA 02215.
  • Morris E; Novartis Institute of Biomedical Research, Oncology Drug Discovery, Cambridge, MA 02139.
  • Halilovic E; Novartis Institute of Biomedical Research, Oncology Drug Discovery, Cambridge, MA 02139.
  • Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA ; Harvard Medical School, Boston, MA 02215. Anthony_Letai@dfci.harvard.edu.
Haematologica ; 109(4): 1253-1258, 2024 Apr 01.
Article em En | MEDLINE | ID: mdl-37881837

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-bcl-2 / Antineoplásicos Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-bcl-2 / Antineoplásicos Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article